BioGaia AB (FRA:BGLA) Cyclically Adjusted FCF per Share: €0.25 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:BGLA BioGaia AB FRA:BGLA
94 GF Score
Price €10.45
GF Value €11.52
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is BioGaia AB Cyclically Adjusted FCF per Share?

BioGaia AB FRA:BGLA -0.85% 94 Cyclically Adjusted FCF per Share is €0.25 as of Mar. 2026. GuruFocus rates FRA:BGLA with a GF Score™ of 94/100 and a GF Value™ of €11.52 (Fairly Valued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

BioGaia AB's adjusted free cash flow per share for the three months ended in Mar. 2026 was €0.063. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €0.25 for the trailing ten years ended in Mar. 2026.

During the past 12 months, BioGaia AB's average Cyclically Adjusted FCF Growth Rate was 8.40% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 10.60% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 9.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of BioGaia AB was 10.60% per year. The lowest was 6.10% per year. And the median was 8.30% per year.

As of today (2026-07-17), BioGaia AB's current stock price is €10.45. BioGaia AB's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was €0.25. BioGaia AB's Cyclically Adjusted Price-to-FCF of today is 41.80.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of BioGaia AB was 74.34. The lowest was 35.11. And the median was 47.35.


BioGaia AB  (FRA:BGLA) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

BioGaia AB's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=10.45/0.25
=41.80

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of BioGaia AB was 74.34. The lowest was 35.11. And the median was 47.35.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


BioGaia AB Cyclically Adjusted FCF per Share Related Terms


BioGaia AB Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for BioGaia AB's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioGaia AB Cyclically Adjusted FCF per Share Chart

BioGaia AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.19 0.19 0.22 0.23 0.26

BioGaia AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.24 0.24 0.25 0.26 0.25

FRA:BGLA vs ZTS, UTHR: Cyclically Adjusted FCF per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, BioGaia AB's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioGaia AB Cyclically Adjusted Price-to-FCF vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, BioGaia AB's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where BioGaia AB's Cyclically Adjusted Price-to-FCF falls into.


FRA:BGLA
94GF Score
BioGaia AB FRA:BGLA
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BioGaia AB Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, BioGaia AB's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.063/133.5600*133.5600
=0.063

Current CPI (Mar. 2026) = 133.5600.

BioGaia AB Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 0.014 101.019 0.019
201609 0.063 101.138 0.083
201612 0.054 102.022 0.071
201703 0.094 102.022 0.123
201706 0.015 102.752 0.019
201709 0.046 103.279 0.059
201712 0.079 103.793 0.102
201803 0.045 103.962 0.058
201806 0.031 104.875 0.039
201809 0.080 105.679 0.101
201812 0.035 105.912 0.044
201903 0.034 105.886 0.043
201906 0.024 106.742 0.030
201909 0.057 107.214 0.071
201912 0.002 107.766 0.002
202003 0.073 106.563 0.091
202006 0.034 107.498 0.042
202009 0.057 107.635 0.071
202012 0.054 108.296 0.067
202103 0.040 108.360 0.049
202106 0.054 108.928 0.066
202109 0.064 110.338 0.077
202112 0.051 112.486 0.061
202203 0.083 114.825 0.097
202206 0.073 118.384 0.082
202209 0.039 122.296 0.043
202212 0.083 126.365 0.088
202303 0.086 127.042 0.090
202306 0.068 129.407 0.070
202309 0.075 130.224 0.077
202312 0.095 131.912 0.096
202403 0.038 132.205 0.038
202406 0.103 132.716 0.104
202409 0.085 132.304 0.086
202412 0.087 132.987 0.087
202503 0.032 132.825 0.032
202506 0.068 133.699 0.068
202509 0.098 133.480 0.098
202512 0.075 133.390 0.075
202603 0.063 133.560 0.063

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of €0.25 mean?
BioGaia AB (FRA:BGLA) has a Cyclically Adjusted FCF per Share of €0.25 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on BioGaia AB and its competitors.
Is BioGaia AB's Cyclically Adjusted FCF per Share too high?
BioGaia AB's current Cyclically Adjusted FCF per Share is €0.25. Overall, BioGaia AB has a GF Score™ of 94/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does BioGaia AB's Cyclically Adjusted FCF per Share compare to ZTS and UTHR?
BioGaia AB's Cyclically Adjusted FCF per Share of €0.25 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Drug Manufacturers company?
A good Cyclically Adjusted FCF per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on BioGaia AB and its competitors. BioGaia AB's current Cyclically Adjusted FCF per Share is €0.25. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioGaia AB stock overvalued right now?
Based on GuruFocus' analysis, BioGaia AB (FRA:BGLA) is currently considered Fairly Valued. The stock's GF Value™ is €11.52, compared to a current price of €10.45 — trading 9.3% below its estimated fair value. The current Cyclically Adjusted FCF per Share is €0.25. BioGaia AB's overall GF Score™ is 94/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For BioGaia AB (FRA:BGLA), the current Cyclically Adjusted FCF per Share is €0.25 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BioGaia AB (FRA:BGLA) Overvalued in 2026?

Based on GuruFocus' analysis, BioGaia AB stock appears to be undervalued. The current stock price of €10.45 is trading 9.3% below its estimated GF Value™ of €11.52. GuruFocus considers BioGaia AB to be Fairly Valued.

Key valuation signals for FRA:BGLA:

  • Cyclically Adjusted FCF per Share: €0.25
  • GF Value™: €11.52 vs. price of €10.45 (9.3% below fair value)
  • GF Score™: 94/100 with 2 warning signs

No single metric tells the full story. See the FRA:BGLA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


BioGaia AB Business Description

Address Kungsbroplan 3A, Stockholm, SWE, SE-112 27
BioGaia AB is a healthcare company engaged in developing, marketing, and selling probiotic products. The company has three operating segments; Paediatrics segment includes drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products such as infant formula, as well as royalty revenue for pediatric products, Adult Health segment includes gut health tablets, oral health lozenges and cultures as an ingredient in a licensee's dairy products, and Other segment include royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc. Geographically, it operates in three regions: EMEA, the Americas, and APAC (Asia-Pacific, Australia, and New Zealand).
94GF Score

Get the complete analysis for FRA:BGLA

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€10.45
Price
€11.52
GF Value